publication venue for
- INVESTIGATING THE EFFECTS OF FLUID COMPOSITION ON BACTERIAL AEROSOL PRODUCTION 2022
- IN VITRO EVALUATION OF THE AEROGEN MICROPUMP AEROSOL DELIVERY SYSTEM FOR DELIVERING ADHU5AG85A TB VACCINE TO HUMAN SUBJECTS 2015
- CURRENT METHODS FOR LUNG IMAGING OF AEROSOL DEPOSITION FROM MEDICAL INHALERS: GUIDELINES FROM THE ISAM TASK FORCE REPORT 2013
- Re: “Harmonizing the Nomenclature for Therapeutic Aerosol Particle Size: A Proposal” by Hillyer et al. (J Aerosol Med Pulm Drug Deliv. 2018 [31(2):111–113]; DOI: 10/1089/jamp.2017.1396). 31:266-268. 2018
- Methacholine Challenge: Comparison of Airway Responsiveness Produced by a Vibrating Mesh Nebulizer Versus a Jet Nebulizer. 31:88-93. 2018
- Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM Workshop. 30:1-13. 2017
- Positron Emission Tomography (PET) for Assessing Aerosol Deposition of Orally Inhaled Drug Products. 25:S52-S71. 2012
- Standardization of Techniques for Using Planar (2D) Imaging for Aerosol Deposition Assessment of Orally Inhaled Products. 25:S10-S28. 2012
- Standards for Lung Imaging Techniques. 25:S1-S2. 2012
- Clinically Relevant Test Methods to EstablishIn VitroEquivalence for Spacers and Valved Holding Chambers Used with Pressurized Metered Dose Inhalers (pMDIs). 25:217-242. 2012
- Equivalence Considerations for Orally Inhaled Products for Local Action—ISAM/IPAC-RS European Workshop Report. 25:117-139. 2012
- The Direct Effect of Hyperosmolar Agents on Ciliary Beating of Human Bronchial Epithelial Cells. 25:88-95. 2012
- Deposition, Imaging, and Clearance: What Remains to be Done?. 23:S39-S57. 2010
- In VitroEstimations ofIn VivoJet Nebulizer Efficiency Using Actual and Simulated Tidal Breathing Patterns. 18:427-438. 2005
- Measuring Total and Regional Lung Deposition Using Inhaled Radiotracers. 14:35-44. 2001
- Consensus Statement: Aerosols and Delivery Devices. 13:291-300. 2000
- New Propellant-Free Technologies under Investigation. 12:S9-17. 1999
- Estimation of Pulmonary Deposition of Aerosol Using Gamma Scintigraphy. 12:9-15. 1999
- Impact of Oropharyngeal Deposition on Inhaled Dose. 11:S112-S115. 1998
- In Vitro Measurements of Delivery of Medications from MDIs and Spacer Devices. 9:S49-S58. 1996
- Clinical Comparisons of Inhaler Systems: What are the Important Aspects?. 8:S39-S46. 1995
- Aerosols as Diagnostic Tools. 7:77-88. 1994
- Standards for In Vitro/In Vivo Measurements of MDI Characteristics: Yea or Nay?. 6:123-124. 1993
- Aerosol Delivery During Mechanical Ventilation: A Predictive In-Vitro Lung Model. 5:251-259. 1992
- Risk of Second-Hand Exposure to Aerosol Pentamidine. 5:11-17. 1992
- Measurement of Particle Size Characteristics of Metered Dose Inhaler (MDI) Aerosols. 4:251-263. 1991